Patients with systemic lupus erythematosus (SLE) seen in dedicated lupus clinics (LC) had better quality measure (QM) performance than in general rheumatology clinics (GRC), according to a recent cross-sectional, single center study. Researchers also found indicators that suggested rheumatologists with higher SLE patient volume provide better quality of care. 150 consenting, consecutive SLE patients receiving longitudinal care at a university-based GRC (n=73) and subspecialty LC (n=77) were recruited. An updated QM survey and retrospective medical chart review was used for evaluation of each QM. The overall and individual (n=20) QM performance was calculated and compared between the 2 groups. They found:
- Overall QM performance was significantly greater among LC SLE patients (85.8% vs. 70.2%).
- Differences noted among the 2 groups were in sunscreen counseling (98.7% vs 83.6%), antiphospholipid antibody testing (71.4% vs 37%), pneumococcal vaccination (84.8% vs 48.8%), BMD testing (94.2% vs 54.5%), drug counseling (92.2% vs 80.8%), steroid sparing agent and ACE inhibitor use (100% vs 82%, and 94.4% vs 58.3%, respectively), and cardiovascular disease risk assessment (40.3% vs 15.1%).
Arora S, Nika A, Trupin L, et al. Does SLE care provided in a lupus clinic result in higher quality of care than general rheumatology clinic? [Published online ahead of print April 2, 2018]. Arthritis Care Res. doi:10.1002/acr.23569.
This Week's Must Reads
Treating Patients with RA Who Have Cancer, Arthritis Care Res; ePub 2019 Mar 1; Lopez-Olivo, et al
Impact, Timing of Smoking Cessation on RA Risk, Arthritis Care Res; ePub 2019 Feb 21; Liu, et al
HLA-DRB1 Haplotypes and RA Disease Outcomes, J Rheumatol; ePub 2019 Mar 1; Zhao, Mauer, et al
Myocardial Inflammation and Disease Activity in RA , Arthritis Rheumatol; ePub 2019 Feb 28; Amigues, et al
Multibiomarker Disease Activity Testing for RA , J Rheumatol; 2019 Mar; Curtis, Xie, Yang, et al
Must Reads in Lupus & Connective Tissue Diseases
African American Scleroderma Patients and Mortality, Arthritis Care Res; ePub 2019 Mar 1; Moore, et al
Inflammatory Arthritis a Risk for THA Complications , J Arthroplasty; ePub 2019 Feb 18; Richardson, et al
Remission/Low Disease Activity Protective in SLE , Lupus; ePub 2019 Jan 24; Alarcón, Ugarte-Gil, et al
List of medications linked to drug-induced lupus expands, Arnaud L et al. Ann Rheum Dis. 2019 Feb 4. doi: 10.1136/annrheumdis-2018-214598